Company:  SYNTA PHARMACEUTICALS COR ... (SNTA)
Form Type:  10-K
Filing Date:  2/22/2012 
CIK:  0001157601 
Address:  45 HARTWELL AVE 
City, State, Zip:  LEXINGTON, Massachusetts 02421 
Telephone:  781-274-8200 
Last Trade
Last Trade: 
$7.39   		Change: 
-0.12 (-1.60%)  
Trade Time: 
May 22   		Market Cap: 
$510.89M
Description of Business
Register for a Free Trial and access this filing in:     
  FORM 10-K
    PART I
      Item 1. BUSINESS
      Item 1A. RISK FACTORS
      Item 1B. UNRESOLVED STAFF COMMENTS
      Item 2. PROPERTIES
      Item 3. LEGAL PROCEEDINGS
      Item 4. MINE SAFETY DISCLOSURES
    PART II
      Item 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED ...
      Item 6. SELECTED FINANCIAL DATA
      Item 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL ...
        Consolidated Results of Operations
        Liquidity and Capital Resources
      Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT ...
      Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
      Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ...
      Item 9A. CONTROLS AND PROCEDURES
      Report of Independent Registered Public Accounting Firm
      Item 9B. OTHER INFORMATION
    PART III
      Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
      Item 11. EXECUTIVE COMPENSATION
      Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS ...
      Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, ...
      Item 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
    PART IV
      Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
    SIGNATURES
    Report of Independent Registered Public Accounting Firm
    BALANCE SHEET
    INCOME STATEMENT
    STOCKHOLDERS EQUITY
    CASH FLOW
    Notes to Consolidated Financial Statements
  EXHIBIT 10.6.4
  EXHIBIT 23.1
  EXHIBIT 31.1
    CERTIFICATIONS UNDER SECTION 302
  EXHIBIT 31.2
    CERTIFICATIONS UNDER SECTION 302
  EXHIBIT 32.1
    CERTIFICATIONS UNDER SECTION 906
© 1995-2013 EDGAR Online, Inc. All rights reserved • NASDAQ: EDGR • Solutions for Corporations • Terms of Use • Privacy Statement